NeurologyLive® Year in Review 2025: Roundtable Roundup – Reviewing this Year’s Launched Programming
Key Takeaways
- Neurology is evolving with new therapies, diagnostic tools, and care models, requiring integration of emerging evidence and addressing clinical challenges.
- Expert discussions cover diverse topics, including narcolepsy, stroke, and multiple sclerosis, emphasizing patient-centered outcomes and interdisciplinary collaboration.
Discover key conversations from leaders in neurology covering a range of different clinically relevant topics.
As neurology continues to evolve at a rapid pace, clinicians are navigating an increasingly complex landscape shaped by emerging therapies, expanding diagnostic tools, and shifting models of care. Across subspecialties, neurologists are being asked to integrate new evidence while addressing long-standing clinical challenges, all amid heightened attention to patient-centered outcomes and interdisciplinary collaboration. In this environment, expert-led discussions offer a valuable opportunity to contextualize new data, share real-world experience, and identify practical takeaways for everyday practice.
Throughout the year, NeurologyLive® conducted multiple roundtables with experts in neurology and related specialties across a range of topics. These discussions provided viewers with direct access to the perspective of key leaders in the field who shared their expertise on lateral sclerosis (ALS), multiple sclerosis (MS), narcolepsy, stroke, neuromuscular diseases, headache medicine, and more. From examining the evolving standard of care across neurological conditions to highlighting personal growth and empowerment within the field, these conversations deliver timely data and practical insights from leading experts.
For this year’s Roundtable Roundup, we selected 8 discussions from 2025 that reflect the breadth and depth of current neurological practice. Below, you can explore highlights from these discussions spanning the full spectrum of neurology.
Expert Insights on Narcolepsy Management From World Sleep Congress 2025
In this roundtable discussion, sleep experts Gerard J. Meskill, MD, and Laura B. Herpel, MD, reviewed real-world data presented at the 2025 World Sleep Congress highlighting advances in narcolepsy management. Panelists discussed key findings related to optimizing treatment strategies, improving adherence and tolerability, and understanding long-term safety outcomes. The conversation also explored data addressing common comorbidities as well as emerging evidence suggesting the need for more tailored approaches for patient subgroups, including those with type 1 versus type 2 narcolepsy.
To view more videos from this roundtable discussion,
Stroke Frontiers: Redefining the Boundaries of Care
In this special Roundtable Discussion, Brian Snelling, MD, neurosurgeon, director of cerebrovascular and endovascular neurosurgery, and director of the stroke program at Marcus Neuroscience Institute, part of Baptist Health South Florida, joins Felipe De Los Rios, MD, neurologist, Irma Bass Endowed Chair in Stroke Neurology, and director of the stroke program at Baptist Health Miami Neuroscience Institute, for an in-depth exploration of the rapidly evolving field of stroke care.
Across five expert-led conversations, Snelling and De Los Rios examine how stroke management is being redefined through expanded thrombectomy eligibility, the integration of artificial intelligence into triage, the pursuit of neuroprotective and cytoprotective agents, new frontiers in post-stroke recovery and secondary prevention, and the creation of efficient, data-driven stroke systems of care. Their insights offer a real-world look at how innovation, coordination, and clinical precision are transforming the standard of care for patients with cerebrovascular disease.
To view more videos from this roundtable discussion,
Highlights From the 2025 LGS Research Meeting of the Minds
In this roundtable discussion, experts Scott Perry, MD, and Gita Gupta, MS, MS, reflected on key themes from 2025 Lennox-Gastaut syndrome (LGS) Research Meeting of the Minds. The conversation addressed pressing gaps in current LGS care, including the need for more effective, individualized treatment strategies and improved access to multidisciplinary resources. Panelists highlighted actionable approaches such as enhancing care coordination, expanding caregiver education, and fostering collaboration among stakeholders. The panel also considered how takeaways from the meeting could influence the design and focus of future clinical trials to better address the diverse needs of patients living with LGS.
To view more videos from this roundtable discussion,
Elevating Women in Neurology: Perspectives From Empowering Leaders
In this compelling panel discussion, neurologists Vanessa Hinson, MD, PhD (Medical University of South Carolina), Carlayne Jackson, MD (UT Health San Antonio) and Marie Eugene, DO (University of Connecticut) explore the evolving role of women in neurology. They share insights into empowering women leaders, their unique contributions to neurology departments, and the challenges they’ve faced as women in the medical workforce. The conversation also highlights groundbreaking women-related research, making this series a must-watch for those passionate about advancing diversity and inclusion in medicine.
To view more videos from this roundtable discussion,
From Criteria to Clarity: MS and Its Impact on Vision
In this roundtable series "From Criteria to Clarity: MS and its Impact on Vision", neurologists Elena Grebenciucova, MD, and Neena Cherayil, MD, dive into the crucial relationship between multiple sclerosis (MS) and the visual system. They explore how ocular symptoms, such as optic neuritis, often serve as early indicators of MS and discuss recent advancements in diagnostic criteria, including the incorporation of optic nerve involvement. The discussion highlights the essential role of neuro-ophthalmologists in MS care, emphasizing their expertise in using advanced diagnostic tools like OCT (optical coherence tomography) and their role in distinguishing MS from other conditions with similar ocular symptoms. The series provides insights into the intersection of MS research, patient care, and the evolving understanding of visual impairments in MS.
To view more videos from this roundtable discussion,
Advances in SMA Treatments: Insights for Neurologists
In ths roundtable series "Advances in SMA Treatments: Insights for Neurologists," experts Diana Bharucha-Goebel, MD, and Bakri Elsheikh, MBBS, FRCP, explore the rapidly evolving landscape of spinal muscular atrophy (SMA) care and the latest guidelines for SMA treatment decisions. Across seven episodes, they cover the latest treatment options, updated best practices, and the growing importance of newborn screening and early diagnosis. The series offers neurologists practical insights on integrating new therapies into clinical practice and highlights the essential role of multidisciplinary care in improving outcomes for patients with SMA.
To view more videos from this roundtable discussion,
Updates in ALS: Research, Genetics, and Holistic Approaches
In this roundtable discussion, Bjorn Oskarsson, MD; John Novak, MD; Christina Fournier, MD, focused on recent advances in ALS research that show potential to improve clinical care, emphasizing the integration of holistic approaches to patient management. Throughout the discussion, experts highlighted the growing role of genetic testing in refining diagnosis and tailoring treatment plans. They also discussed the importance of nonpharmacologic interventions in symptom management and stressed the value of a multidisciplinary team approach to support both patients and caregivers throughout the progression of ALS, aiming to enhance overall outcomes and quality of life.
To view more videos from this roundtable discussion,
Remyelination in Multiple Sclerosis: Where Do We Stand?
In this roundtable discussion, Ari Green, MD, and Paul Tesar, PhD, delve into the current landscape of remyelination in multiple sclerosis (MS), offering expert perspectives on one of the field’s most pressing therapeutic frontiers. The panel explores how our understanding of remyelination has evolved, the tools used to measure it in human studies, and the challenges of translating early scientific success into clinical progress. The conversation also touches on the impact of aging and disease duration on remyelination potential, highlights novel agents in clinical trials, and debates whether remyelination should be pursued as a standalone strategy or in combination with immunomodulatory therapy. Looking ahead, the experts outline the innovations in imaging, trial design, and therapeutic development that could help close the gap between discovery and clinical application.
To view more videos from this roundtable discussion,
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.